Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : British Biotech (BBIOY) -- Ignore unavailable to you. Want to Upgrade?

To: Jake who wrote (27)	5/12/1998 1:44:00 PM
From: gilbert Kuhn	Read Replies (1) \| Respond to of 41

I recently read the entire article from the Financial Times.Something appears to be "wrong" regarding top management. What little I know about the marimastat trials on the West Coast, appear to show favorable results. I don't know why the European FDA did noT allow BBIOY's pancreatitis drug to be released early.I believe that a meeting needs to be had with principle investors and top management and a number of questions need to be answered. This company may be in a lot of trouble if a lot of the rumors floating about are true.